Skip to main content
. 2021 Dec 24;23(1):191. doi: 10.3390/ijms23010191

Figure 2.

Figure 2

Typical modification of extracellular vesicles employed as therapeutic nanocarriers, of endemic and/or loaded cargo (a) surface modification, (b) encapsulation, (c) membrane fusion and (d) exosome-coating of nanoparticles (here shown for metal-organic frameworks, loaded with bioactive compounds).